Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26337,124,1.59 [1.22-2.07],0.0006263212572166
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27082,203,1.07 [0.87-1.32],0.5372259564401114
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26806,1336,1.37 [1.26-1.49],8.518941771651973e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Candidiasis,27110,472,1.27 [1.11-1.46],0.0007341458087241
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26264,3495,1.25 [1.19-1.32],3.720560480827563e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26487,2862,1.22 [1.16-1.30],4.566992762729103e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,26822,1370,1.23 [1.13-1.33],1.2054424781354828e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27003,91,1.09 [0.80-1.50],0.5846859496405408
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25269,815,1.52 [1.37-1.69],1.857824980376372e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24440,954,1.57 [1.43-1.73],4.248016209237706e-21
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24454,259,1.44 [1.19-1.73],0.0001624675008391
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19039,1656,1.26 [1.16-1.36],5.870072269772316e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24221,369,1.51 [1.29-1.76],2.258778969544601e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27051,1599,1.20 [1.11-1.30],2.385424377524317e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Mycoses,27172,534,1.29 [1.13-1.47],0.000170718852068
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26414,944,1.43 [1.29-1.57],7.994361092327967e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27115,902,1.51 [1.36-1.66],3.858717191889361e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25655,203,1.08 [0.88-1.34],0.4613278854772872
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27235,46,1.74 [1.14-2.65],0.0098090823519368
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27001,788,1.51 [1.36-1.68],1.2423240562961481e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,26994,82,0.94 [0.68-1.29],0.6930311070011692
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27135,189,1.21 [0.97-1.50],0.0983065948561266
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27118,172,1.11 [0.88-1.40],0.38155506680289
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25813,343,1.49 [1.27-1.75],9.70221416491592e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,25736,266,1.27 [1.05-1.53],0.011624059390714
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,25583,131,1.28 [0.98-1.68],0.0740635783544174
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27213,36,2.16 [1.37-3.41],0.0009615733726303
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27160,156,1.29 [1.01-1.65],0.0379114129351065
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral warts,27049,45,0.78 [0.52-1.18],0.2444855338068416
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27081,77,1.44 [1.02-2.03],0.039346300795589
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm,26969,241,0.94 [0.78-1.13],0.49445169569754
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27133,71,1.12 [0.78-1.61],0.5272278666185509
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27132,70,0.70 [0.53-0.93],0.0150223835029855
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26951,1216,0.98 [0.90-1.07],0.720869684615782
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of meninges,27207,81,0.97 [0.70-1.36],0.8797557617831406
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27168,63,1.21 [0.82-1.77],0.3387621410690951
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27202,132,0.94 [0.73-1.20],0.6182850335338381
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of ovary,27154,174,0.99 [0.79-1.24],0.9087462850793632
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27214,277,1.07 [0.89-1.28],0.4949057852200995
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Caecum,27220,251,0.95 [0.79-1.15],0.6054749784169698
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27147,64,0.84 [0.59-1.19],0.3323501039753383
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Descending colon,27216,156,1.02 [0.80-1.30],0.8677647681191906
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Rectum,27178,281,0.92 [0.78-1.10],0.3838645647609311
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27135,487,1.10 [0.96-1.27],0.1569798673656263
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27215,297,0.99 [0.83-1.17],0.8912764258361159
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Carcinoma in situ of breast,22090,138,0.92 [0.72-1.19],0.5414425727133408
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22181,166,0.81 [0.65-1.01],0.0565925981060349
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22160,32,1.78 [1.03-3.08],0.0403216795827924
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22194,66,0.95 [0.66-1.37],0.7838838125800411
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27167,135,1.09 [0.84-1.42],0.5137724504118379
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma, any site",27168,133,1.09 [0.84-1.41],0.5356901661797813
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Leiomyoma of uterus,26247,581,0.85 [0.76-0.96],0.0092648204532451
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lung cancer and mesothelioma,19530,313,0.97 [0.82-1.15],0.7295297987328724
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lymphoid leukaemia,22164,36,2.02 [1.23-3.33],0.005709359998005
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22304,176,1.00 [0.79-1.25],0.979511652537832
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22241,113,1.37 [1.02-1.84],0.0349465366625439
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22309,181,0.89 [0.72-1.10],0.2953203854043114
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22198,70,1.40 [0.96-2.03],0.0772065284920228
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22200,72,1.25 [0.87-1.80],0.2350578980087686
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22185,57,1.58 [1.06-2.36],0.0252518599301116
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22268,140,0.90 [0.70-1.16],0.4137586948728045
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22229,101,0.81 [0.62-1.06],0.122632915166139
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22208,80,0.86 [0.62-1.19],0.3650095660547418
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22171,43,0.89 [0.57-1.37],0.5829169808117125
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22210,82,0.92 [0.66-1.28],0.6288851157011879
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi,26972,227,0.86 [0.71-1.05],0.1358079757559046
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi of trunk,27186,78,0.94 [0.67-1.32],0.7146896249322245
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanoma in situ,22161,88,1.05 [0.76-1.46],0.7694940055139683
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22209,81,1.04 [0.74-1.46],0.8230073646169558
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22280,152,1.35 [1.05-1.74],0.0212204874528463
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22358,230,0.86 [0.71-1.04],0.113974577100799
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22222,94,1.51 [1.09-2.08],0.0122317418137259
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Other benign neoplasms of skin,27007,169,1.11 [0.88-1.41],0.3628452973830883
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23046,918,1.05 [0.95-1.16],0.3418174454917106
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23086,958,1.06 [0.96-1.17],0.240916319937635
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26928,376,1.40 [1.20-1.63],2.6917655409006164e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25235,106,1.86 [1.41-2.44],9.193276050254168e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,26622,70,1.69 [1.19-2.41],0.0036530847644972
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26227,2943,1.23 [1.17-1.31],4.308814605021557e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,25605,35,1.46 [0.88-2.42],0.1407549909808125
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,26835,48,2.31 [1.63-3.27],2.256551965917424e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26653,1524,1.21 [1.12-1.30],2.740799753596711e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26653,1524,1.21 [1.12-1.30],2.740799753596711e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25199,70,1.67 [1.18-2.37],0.003744519823398
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26828,1258,1.23 [1.13-1.34],2.9032671888325027e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,26902,115,1.59 [1.21-2.09],0.0008792890899043
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,26603,51,1.35 [0.88-2.07],0.1677197380127827
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,26608,56,1.45 [0.96-2.18],0.0791480769738413
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27024,237,1.75 [1.45-2.11],3.760087491294563e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27123,60,1.82 [1.26-2.65],0.0016080677318121
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",26986,199,1.73 [1.41-2.12],1.1368644930490986e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,25704,134,1.16 [0.89-1.51],0.2687804336429447
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21928,254,1.57 [1.31-1.87],9.61447970876622e-07
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25825,66,0.69 [0.49-0.98],0.0408146747086823
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25819,60,1.16 [0.78-1.72],0.458856586952182
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,21726,52,1.29 [0.85-1.95],0.2379132488683453
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,24978,70,1.05 [0.74-1.50],0.7815430374280932
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,24624,248,1.41 [1.17-1.70],0.0003675220451123
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",26798,508,1.37 [1.19-1.56],6.151677691089412e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,26573,283,1.12 [0.93-1.35],0.2329069811862798
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26378,88,0.89 [0.66-1.22],0.4772579225891519
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,26832,1924,1.06 [0.99-1.14],0.0937790241272355
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24082,1874,1.08 [1.00-1.15],0.0415985523079685
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",21730,56,1.33 [0.89-1.98],0.1594572565619474
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24151,120,1.59 [1.21-2.08],0.0008218448929037
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21958,284,1.24 [1.04-1.49],0.0177460819075021
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21721,47,1.11 [0.71-1.73],0.6363859143025532
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24794,3120,1.05 [0.99-1.10],0.092294594890376
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21873,199,1.32 [1.06-1.63],0.0111565772288019
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22210,536,1.25 [1.10-1.42],0.0009004401385967
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27132,366,1.06 [0.91-1.24],0.4382360174877003
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,26946,180,1.07 [0.86-1.34],0.533817400139361
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,21774,100,1.27 [0.94-1.72],0.1253074955175928
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",21728,54,1.92 [1.34-2.76],0.0004164400252547
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26343,2312,1.13 [1.06-1.21],0.0001174070399498
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21879,205,1.81 [1.50-2.17],4.4684983443353726e-10
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21889,215,1.81 [1.51-2.17],2.1508017674176568e-10
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22200,526,1.00 [0.88-1.14],0.999120357321435
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,21764,90,1.35 [0.99-1.85],0.0613464672304771
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,26936,170,1.08 [0.86-1.35],0.5148556762317413
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22296,622,1.38 [1.22-1.56],2.6569267080584464e-07
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22236,562,1.24 [1.09-1.41],0.0008309579710126
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24447,71,1.32 [0.92-1.89],0.1278187687929886
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26342,4668,1.12 [1.07-1.17],7.017972072240113e-07
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24109,78,0.94 [0.67-1.32],0.7250581373367909
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24119,88,0.91 [0.66-1.25],0.561658328154632
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27040,2064,1.07 [1.00-1.14],0.0483254047783161
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27046,2064,1.06 [1.00-1.14],0.0553667417407757
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24114,83,1.01 [0.73-1.41],0.9517973458556778
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,26826,1584,1.04 [0.96-1.12],0.3332078271195898
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23190,1516,1.30 [1.21-1.41],1.4215628242278852e-11
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27221,183,1.55 [1.25-1.91],6.265395392634238e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26345,55,1.27 [0.84-1.92],0.2567916691334571
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25372,130,0.89 [0.69-1.15],0.3668462796252844
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25440,198,0.97 [0.78-1.19],0.7538535499023749
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21943,269,1.23 [1.02-1.48],0.0308071765405819
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25424,142,1.48 [1.15-1.91],0.0020499576556705
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1687,47,1.00 [0.65-1.55],0.9967823611162148
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1801,185,1.26 [1.02-1.57],0.0337850744443119
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25307,25,1.91 [1.14-3.20],0.014119680261189
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1670,31,1.30 [0.77-2.18],0.3219467780639379
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26746,1464,1.25 [1.15-1.35],3.107830700180284e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,26625,335,1.19 [1.01-1.41],0.0392786367220192
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,24862,486,1.14 [1.00-1.31],0.0557756274527614
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22397,723,1.36 [1.21-1.52],6.83105954403173e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27133,230,1.09 [0.90-1.34],0.3752015310903041
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26231,55,1.62 [1.11-2.37],0.0123526586390889
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Angina pectoris,25711,877,1.09 [0.99-1.21],0.0836801824540937
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26275,99,1.50 [1.12-2.01],0.0066915974145342
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26210,34,1.32 [0.79-2.20],0.2965438497615695
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26330,154,1.15 [0.90-1.47],0.2590153532565848
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17715,1449,1.39 [1.28-1.51],3.1403894780293906e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,AV-block,23862,236,1.21 [0.99-1.47],0.0634875431594001
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27194,304,1.08 [0.91-1.29],0.3576624290309275
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiac arrest,16396,130,1.84 [1.43-2.38],3.0125656739757058e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23762,136,1.26 [0.97-1.64],0.0805432995964445
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",23705,79,1.38 [0.98-1.93],0.0639569529370644
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27230,34,0.95 [0.57-1.59],0.8562227080191767
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Conduction disorders,24347,721,1.26 [1.12-1.41],7.07482813963874e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26326,1504,1.11 [1.03-1.20],0.0084878925662974
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24483,7191,1.14 [1.10-1.19],4.2148688025668934e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25733,244,1.07 [0.88-1.30],0.5071008791537666
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Endocarditis,23686,60,1.59 [1.09-2.30],0.015476896270697
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27138,853,1.45 [1.31-1.61],7.17592175660165e-13
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertension,25100,6078,1.14 [1.09-1.18],1.7655774817986174e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25112,6090,1.14 [1.10-1.19],8.782944217329077e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27129,40,3.01 [2.30-3.93],8.703482091025994e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19188,166,1.62 [1.30-2.02],1.7505695745369468e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19124,102,1.93 [1.52-2.45],6.628154385337903e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypotension,27095,1100,1.22 [1.11-1.34],2.1419227818952257e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,26479,93,1.25 [0.91-1.72],0.1631446658239639
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26523,1689,1.10 [1.03-1.19],0.0083388016095808
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26918,453,1.32 [1.14-1.52],0.000158252472374
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Left bundle-branch block,23925,299,1.31 [1.10-1.56],0.002204043206244
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27012,601,1.09 [0.96-1.23],0.1707025304453201
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25317,483,1.14 [0.99-1.30],0.0705792334311842
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27209,86,1.04 [0.75-1.44],0.8276808919296357
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27229,240,1.04 [0.86-1.26],0.7070804410989373
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Oesophageal varices,25526,37,3.32 [2.35-4.69],1.0158996468029795e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other aneurysm,26236,60,1.50 [1.01-2.22],0.0420177144527182
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arrhythmias,23976,350,1.33 [1.13-1.56],0.0006496014010143
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26242,66,1.37 [0.95-1.97],0.091901715770744
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26369,193,1.35 [1.09-1.68],0.0065808814623665
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,23779,153,1.39 [1.09-1.76],0.0084018348442157
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other disorders of veins,25584,95,1.04 [0.76-1.41],0.8161205895711139
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,25534,45,1.24 [0.79-1.96],0.3518135504873587
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26000,39,1.12 [0.69-1.83],0.6350908484090441
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,25653,164,1.16 [0.92-1.48],0.2179932858008044
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24425,799,1.39 [1.25-1.54],4.015150439877711e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26037,42,2.47 [1.75-3.50],3.365478869559972e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26670,494,1.27 [1.11-1.46],0.0005034211754619
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26659,323,1.50 [1.28-1.77],1.0981299209198475e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",26494,533,1.12 [0.98-1.28],0.0837590076205334
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16556,290,1.22 [1.01-1.46],0.0347789947846134
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26434,271,1.29 [1.08-1.55],0.0060128010095548
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25811,322,1.17 [0.98-1.38],0.0751682078294944
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26781,445,1.22 [1.06-1.41],0.0070228819837606
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27156,587,1.43 [1.27-1.62],1.1244310332470377e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Right bundle-branch block,23842,216,1.26 [1.03-1.56],0.0275907925185322
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26651,315,1.52 [1.29-1.79],6.541470122350826e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26117,156,1.29 [1.01-1.64],0.0374538497867074
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26911,525,1.29 [1.13-1.47],0.0001574559040881
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26886,571,1.33 [1.17-1.50],1.3795634274255772e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26446,69,1.25 [0.87-1.79],0.2299432937777002
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26223,47,1.11 [0.71-1.74],0.6365354375532939
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26682,217,0.95 [0.78-1.16],0.6241862990904977
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26609,198,0.97 [0.78-1.20],0.7629503490643356
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Varicose veins,25943,454,1.14 [0.99-1.32],0.073076353665587
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26189,97,1.16 [0.85-1.58],0.3469656309370467
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27024,702,1.20 [1.07-1.34],0.0021161539018203
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27190,212,1.03 [0.84-1.27],0.7627895974843493
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24192,1848,1.03 [0.96-1.11],0.3695132299886866
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Any mental disorder,26616,4272,1.05 [1.00-1.10],0.0307803278037158
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27158,252,0.98 [0.81-1.19],0.8613620252940926
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24288,1944,1.08 [1.00-1.15],0.0370651413439991
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22437,93,0.91 [0.68-1.22],0.531220749029881
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Smoking dependency,26819,1181,1.11 [1.01-1.20],0.0221102202331293
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23703,1359,1.08 [0.99-1.17],0.0678715055797895
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Vascular dementia,26735,102,1.48 [1.10-1.99],0.010165827114665
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Alzheimer disease,27234,353,1.03 [0.88-1.21],0.708772948135689
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",18593,58,1.16 [0.77-1.74],0.4797828745116798
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Bell's palsy,25088,84,1.51 [1.10-2.09],0.011615897292632
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25630,626,0.97 [0.86-1.09],0.5804842060318915
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral cysts,26832,217,1.21 [0.99-1.49],0.0649611052555237
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27162,279,1.35 [1.13-1.62],0.000945714066601
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,26755,40,0.94 [0.59-1.49],0.783401634628781
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27221,46,1.63 [1.06-2.50],0.0265750909566107
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",26668,53,1.38 [0.91-2.10],0.1270295672418245
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Epilepsy,25759,277,1.11 [0.92-1.33],0.2798726916338091
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26815,1333,1.03 [0.95-1.12],0.4650586440386346
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27185,514,1.14 [0.99-1.30],0.0647364590580667
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26600,2878,1.07 [1.01-1.13],0.0153769822724122
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Generalized epilepsy,26871,47,0.90 [0.59-1.38],0.6253756776067152
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hemiplegia,27106,223,1.49 [1.23-1.82],6.698600917372123e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hydrocephalus,26680,65,1.09 [0.75-1.59],0.6502079001104704
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27214,78,1.29 [0.91-1.82],0.148200070446316
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25128,124,0.88 [0.68-1.14],0.3377202222146539
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25069,65,1.55 [1.07-2.23],0.0198963652736299
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Memory loss,26610,96,0.93 [0.69-1.26],0.6473052463910691
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Migraine,25985,503,1.02 [0.89-1.17],0.7661166589046028
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27118,451,0.96 [0.84-1.10],0.5746209058565792
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Motor neuron disease,18678,119,0.96 [0.73-1.26],0.7587106233678603
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27014,145,1.01 [0.79-1.29],0.9397591128469932
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26382,1378,0.99 [0.91-1.07],0.7330833542065818
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Neurological diseases,25615,3774,1.06 [1.01-1.11],0.018131340608797
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,26872,157,1.11 [0.87-1.42],0.3919186253515704
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25424,420,0.89 [0.77-1.03],0.1110433819673071
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27176,235,1.34 [1.10-1.64],0.0031499636254076
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21934,658,1.06 [0.94-1.19],0.3673528189652444
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,26680,65,1.16 [0.80-1.69],0.4385067438990965
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other disorders of nervous system,26739,124,1.10 [0.84-1.43],0.5008125619575604
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,26859,188,1.31 [1.05-1.64],0.0169260758347044
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25098,94,1.44 [1.06-1.97],0.0192538828938769
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other headache syndromes,25558,76,1.03 [0.74-1.46],0.844286297201567
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other neurological diseases,27115,500,1.16 [1.01-1.33],0.0339071807856366
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other sleep disorders,25884,402,1.05 [0.90-1.22],0.5269467652942021
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Parkinson's disease,27210,311,1.06 [0.89-1.26],0.4968617515032777
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,26697,82,0.82 [0.60-1.12],0.2074229150649659
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Restless leg syndrome,27233,104,1.38 [1.02-1.85],0.0338595193161362
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Sleep apnoea,27056,319,1.04 [0.88-1.23],0.6230974104104314
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Small fibre neuropathy,26981,40,1.13 [0.70-1.83],0.6234847384323463
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27224,148,0.91 [0.72-1.16],0.4515051032045051
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25069,65,1.31 [0.90-1.90],0.1612158525048688
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27234,357,1.03 [0.88-1.22],0.6783738722384784
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),26692,99,1.45 [1.07-1.97],0.0157547796541538
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,26657,111,0.94 [0.71-1.25],0.6821148877283596
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,26766,476,0.99 [0.86-1.14],0.9131476329626914
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27089,171,1.53 [1.22-1.91],0.0001795023979859
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26119,58,0.87 [0.59-1.27],0.4724037806646769
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26115,54,1.45 [0.96-2.20],0.0761113671604471
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27113,60,1.38 [0.93-2.03],0.1081705177143085
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,26949,164,1.03 [0.82-1.31],0.7919730399961158
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1676,36,1.45 [0.92-2.29],0.1126096602751838
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2020,68,0.92 [0.64-1.32],0.6389344163667092
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,26632,86,0.98 [0.71-1.34],0.8797929141330737
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27053,1051,1.13 [1.03-1.24],0.0109118876607424
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26816,755,1.02 [0.91-1.14],0.7211638400848337
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26361,300,1.04 [0.87-1.23],0.689390092456588
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27142,852,1.01 [0.91-1.12],0.8562175509327422
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27217,71,1.13 [0.79-1.62],0.4923861441516839
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27064,774,1.02 [0.91-1.13],0.769168441245834
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27187,402,1.07 [0.92-1.24],0.4047337385589021
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27139,204,1.05 [0.85-1.29],0.6565847349857259
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26103,42,1.20 [0.75-1.93],0.4477743428262398
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26108,47,1.19 [0.77-1.85],0.4394132612218697
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26127,66,0.91 [0.63-1.31],0.6042909149575041
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27148,719,1.00 [0.90-1.12],0.9595416183288056
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,26610,181,1.15 [0.92-1.45],0.2140247737594994
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26360,70,0.96 [0.67-1.37],0.8209961682605401
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,26887,102,1.08 [0.80-1.46],0.6141860297014679
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27092,307,1.05 [0.89-1.25],0.560233609273413
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,26500,210,1.11 [0.90-1.37],0.3193365084606375
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27068,133,1.10 [0.84-1.43],0.4839162478330884
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26904,475,1.07 [0.93-1.23],0.3135232760213883
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,26698,152,0.99 [0.78-1.26],0.924428384783658
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25446,2481,1.06 [1.00-1.13],0.0591691860076625
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27053,268,1.12 [0.93-1.35],0.242008168836418
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27211,153,1.25 [0.97-1.60],0.0797471190625234
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26450,389,0.91 [0.78-1.06],0.2100260259110627
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,26849,64,0.88 [0.61-1.26],0.4734149665491834
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27202,56,1.15 [0.77-1.72],0.4995501980851827
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26154,93,1.13 [0.82-1.55],0.4455178152517675
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26216,155,0.88 [0.69-1.11],0.2728353569882373
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26111,109,1.07 [0.80-1.43],0.6588687201730581
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26363,73,1.19 [0.83-1.70],0.3335563617779932
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26062,60,1.54 [1.04-2.28],0.0293274115826463
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,26548,119,0.77 [0.60-0.99],0.0452185677744499
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",26603,174,0.97 [0.77-1.22],0.7850090310679452
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26191,130,0.84 [0.66-1.08],0.1767868921948941
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26101,99,0.94 [0.70-1.26],0.6665779928726844
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26076,74,1.49 [1.05-2.12],0.0249462214021894
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25056,2091,1.05 [0.98-1.12],0.1829324374430522
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26148,87,1.11 [0.80-1.54],0.5370796911969016
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,26973,427,1.03 [0.89-1.19],0.7371124879469158
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,26592,46,1.53 [0.98-2.38],0.0619181074328815
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),26707,161,1.51 [1.19-1.91],0.0006585543082159
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,26994,112,0.97 [0.74-1.28],0.8425725372608354
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27187,117,1.13 [0.85-1.50],0.3882810425566266
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27110,141,1.20 [0.93-1.55],0.1696383051021261
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,26952,70,1.26 [0.88-1.82],0.2080365844046489
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,26948,66,0.90 [0.62-1.29],0.5573190207005303
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27135,805,1.14 [1.02-1.27],0.0177105246447261
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,26882,552,1.13 [0.99-1.28],0.0652930964188298
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26454,124,0.96 [0.74-1.25],0.7671039056179632
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26412,82,1.46 [1.05-2.03],0.025283642060778
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute pharyngitis,26961,87,1.25 [0.90-1.74],0.1754385070564008
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27107,233,1.30 [1.06-1.58],0.0108351769571334
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,26939,65,1.59 [1.10-2.30],0.0136961239684952
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza,25525,125,1.61 [1.24-2.09],0.0003279785501065
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),25523,123,1.64 [1.26-2.12],0.0002231782112539
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19341,124,0.90 [0.69-1.17],0.4397396946617177
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic rhinitis,27082,288,1.02 [0.85-1.21],0.8628646560516249
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21075,2043,1.10 [1.03-1.18],0.0065347441269248
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21234,2017,1.10 [1.03-1.18],0.0060910538454469
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),26816,123,1.37 [1.05-1.80],0.0216921820955448
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25466,66,1.15 [0.79-1.68],0.4561524986621558
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bronchiectasis,23566,411,1.21 [1.04-1.40],0.0140780776607027
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23227,72,1.15 [0.81-1.64],0.4419234186387121
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26093,2938,1.12 [1.06-1.18],0.0001190668072348
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",25949,63,1.22 [0.83-1.79],0.3198837149043877
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic sinusitis,26032,146,1.00 [0.78-1.29],0.9696599919273718
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27060,1052,1.19 [1.08-1.30],0.000278819928552
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Deviated nasal septum,25961,75,0.74 [0.54-1.01],0.0557702821495725
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25162,5130,1.12 [1.08-1.17],6.315976880306427e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26221,335,0.99 [0.85-1.17],0.9515092720310372
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Early onset COPD,26324,316,1.28 [1.08-1.53],0.0046036713771453
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Emphysema,23426,271,1.31 [1.11-1.56],0.001885311597762
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25614,231,1.57 [1.29-1.90],4.643567474912363e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27037,1637,1.31 [1.22-1.41],1.4170687469315713e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Interstitial lung disease,25652,269,1.55 [1.30-1.86],1.5652046786694583e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Later onset COPD,26323,736,1.16 [1.04-1.30],0.0090678175727584
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27226,230,1.38 [1.13-1.68],0.0015675050263099
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Nasal polyp,25955,69,1.05 [0.73-1.51],0.7941714715093775
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27012,920,1.21 [1.10-1.34],0.0001789025699196
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of pleura,27044,1738,1.25 [1.16-1.34],1.515641135337786e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26679,793,0.99 [0.89-1.10],0.8417948539429064
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other pleural conditions,25341,35,1.09 [0.65-1.82],0.7412292575887847
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27154,345,1.54 [1.31-1.81],9.351611943693317e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27144,1181,1.27 [1.16-1.38],1.401746213058948e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural effusion,26148,842,1.28 [1.15-1.42],4.771463235256215e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural plaque,25348,42,1.04 [0.65-1.66],0.8579261188629052
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26805,1405,1.34 [1.24-1.45],1.0330966257050469e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27195,199,1.33 [1.07-1.65],0.0097620019312523
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumothorax,25394,88,1.00 [0.73-1.38],0.9983931777786512
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pollen allergy,27204,239,1.01 [0.83-1.23],0.9018540737606764
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pulmonary oedema,26873,64,1.67 [1.17-2.37],0.0044884823926398
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19269,52,1.68 [1.15-2.46],0.007868309322743
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26988,896,1.22 [1.11-1.35],8.753285543357361e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26174,288,1.02 [0.85-1.21],0.8574542378601882
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Viral pneumonia,25616,216,1.22 [0.99-1.50],0.0620869397027808
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",26830,170,1.30 [1.04-1.64],0.0234939108940666
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13158,107,1.10 [0.82-1.48],0.5213198926268674
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19439,37,1.22 [0.74-2.00],0.4406569108980102
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute appendicitis,27048,141,0.84 [0.66-1.08],0.1715317628088056
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute gastritis,20445,88,1.12 [0.81-1.55],0.5027163128890748
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis,24958,163,1.10 [0.87-1.39],0.4458393235008393
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute peritonitis,26661,85,1.46 [1.05-2.02],0.0230589335858081
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26360,29,1.47 [0.84-2.56],0.1762335106371187
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Barrett oesophagus,20689,332,1.05 [0.89-1.24],0.558454674126274
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",24874,79,1.25 [0.89-1.75],0.1991889240332675
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",26803,79,1.23 [0.88-1.72],0.2298842269246629
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholecystitis,24981,186,1.21 [0.97-1.51],0.0892616907119039
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholelithiasis,25964,1169,1.15 [1.05-1.25],0.0022569160965192
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic gastritis,20692,335,1.08 [0.91-1.27],0.3869696724525433
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic pancreatitis,24838,43,1.30 [0.81-2.07],0.275236804184934
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27156,67,1.95 [1.42-2.68],3.352556851011249e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Coeliac disease,25675,152,1.66 [1.30-2.12],4.098894639634675e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Collagenous colitis,25356,111,0.95 [0.72-1.26],0.7315581161167225
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27096,148,1.19 [0.93-1.53],0.1720318848341081
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Constipation,26890,1714,1.14 [1.06-1.23],0.0003210896089988
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn disease,25340,95,1.69 [1.24-2.31],0.0008423757784515
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26874,71,1.75 [1.25-2.45],0.0012265094304257
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25344,99,1.87 [1.39-2.51],3.240942578431618e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Dental caries,26409,229,1.23 [1.01-1.51],0.0435924708863763
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25621,2449,1.04 [0.97-1.10],0.2617663594144231
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of appendix,27091,184,0.86 [0.69-1.06],0.1547496105451162
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of liver,27136,805,1.26 [1.13-1.40],2.153317440195292e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24958,4601,1.07 [1.02-1.12],0.0040842599770192
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26767,587,1.14 [1.00-1.29],0.0449729941756946
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27111,535,1.13 [1.00-1.29],0.0584998431915938
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26299,119,1.29 [0.97-1.70],0.0758485747490505
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26145,63,1.36 [0.93-1.99],0.1159838549672308
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26939,1416,1.16 [1.07-1.26],0.000236141134195
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of tongue,26155,110,0.99 [0.74-1.32],0.9382901594505152
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26369,1574,1.16 [1.08-1.25],0.0001216845771867
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22565,3163,1.06 [1.00-1.12],0.0350232639623108
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Duodenal ulcer,20486,129,1.07 [0.82-1.39],0.6118174364239508
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27184,109,1.03 [0.77-1.37],0.8485309366263739
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27131,64,1.48 [1.01-2.16],0.0448993150926142
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26420,89,1.79 [1.34-2.40],9.297689365220604e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19511,109,1.14 [0.85-1.52],0.3838098608310696
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Functional dyspepsia,21015,658,1.09 [0.97-1.23],0.1461954830295668
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastric ulcer,20699,342,1.13 [0.96-1.33],0.1337656941147687
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23138,2781,1.07 [1.01-1.13],0.0284635262859681
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20818,461,1.10 [0.96-1.27],0.1757580551980485
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21317,8398,1.09 [1.05-1.13],5.249318959504777e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,GI-bleeding,26669,1146,1.12 [1.02-1.22],0.0158742506090742
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26243,63,1.18 [0.81-1.74],0.3882825594526596
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20367,1256,1.08 [0.99-1.17],0.0938850056609285
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26370,39,1.94 [1.27-2.98],0.0022872738923814
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Hernia,26053,2881,1.05 [0.99-1.11],0.1048202146799703
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impacted teeth,27142,59,1.54 [1.03-2.28],0.0335504800889283
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impaction of intestines,19466,64,1.50 [1.03-2.18],0.0336831195942605
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Inguinal hernia,23335,163,1.22 [0.96-1.55],0.1104875927627329
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19505,103,1.47 [1.09-1.98],0.0115992983227103
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25701,178,1.61 [1.28-2.01],3.741802326752629e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20216,814,1.09 [0.98-1.21],0.1237967854477223
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27219,358,1.32 [1.13-1.54],0.000593155308837
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26056,811,1.20 [1.08-1.33],0.0009686074771764
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26336,1091,1.17 [1.07-1.28],0.0009341598919168
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20517,160,1.11 [0.87-1.41],0.3865926132707691
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophagitis,20924,567,1.10 [0.97-1.25],0.1443946917858014
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27189,158,0.97 [0.77-1.23],0.8054746498074501
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23230,58,1.32 [0.89-1.96],0.1661362469431647
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20665,1263,1.13 [1.03-1.23],0.0062824849683963
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25097,302,1.16 [0.98-1.38],0.0925936049956579
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,24980,185,1.23 [0.99-1.54],0.0640240581237413
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestine,20981,1579,1.10 [1.02-1.19],0.0137263320832634
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestines,25071,5669,1.07 [1.03-1.12],0.0004988796596719
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26150,234,1.00 [0.82-1.22],0.9870499803340016
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of liver,27009,678,1.33 [1.19-1.49],1.236577182751652e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20932,575,1.01 [0.89-1.14],0.8905506271303476
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of pancreas,24950,155,1.32 [1.04-1.69],0.0245951876735784
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27050,474,1.11 [0.97-1.28],0.1337799567836284
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21433,1076,1.08 [0.99-1.19],0.0840630712120192
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26688,1165,1.11 [1.02-1.22],0.0185606522229224
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26370,190,1.22 [0.98-1.52],0.0766886785857776
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21169,1767,1.16 [1.08-1.25],5.5834237951533526e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22470,2113,1.09 [1.02-1.17],0.0074646222666918
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26428,97,1.50 [1.12-2.02],0.0067822002877019
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26206,961,1.16 [1.05-1.28],0.0037000663582598
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19730,328,1.22 [1.03-1.45],0.0190534953559902
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27120,73,1.29 [0.90-1.84],0.1693169339209082
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19896,494,1.20 [1.05-1.38],0.009302176540371
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25654,131,1.16 [0.89-1.51],0.2713359711093446
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27226,70,1.27 [0.88-1.83],0.2004183213954597
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26182,128,1.37 [1.05-1.80],0.0209673202060348
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Toxic colitis,25312,67,1.44 [0.99-2.10],0.0536485031402766
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20589,232,1.09 [0.90-1.33],0.3764728121931965
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcerative colitis,25412,167,1.24 [0.97-1.57],0.0801424364670118
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25383,138,1.28 [0.99-1.67],0.0634001389741406
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Umbilical hernia,23343,171,1.17 [0.93-1.47],0.1902303157471422
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19592,190,1.21 [0.97-1.51],0.0971477664201127
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ventral hernia,23427,255,1.19 [0.98-1.43],0.0774172801733456
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Volvulus,19490,88,1.00 [0.73-1.38],0.9878729162889656
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27145,256,0.99 [0.82-1.20],0.9416368224996332
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,26913,76,1.51 [1.07-2.12],0.0198677376244825
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25169,221,1.00 [0.81-1.22],0.9626695605109424
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26700,618,1.29 [1.14-1.45],4.2850511302494e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26225,143,1.30 [1.01-1.68],0.044122052771301
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25285,337,1.47 [1.25-1.72],3.027738177803409e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,26924,285,1.27 [1.06-1.53],0.008751280627159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27125,486,1.27 [1.10-1.45],0.0007563345952952
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,26687,48,1.53 [1.00-2.36],0.0517142990196247
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25632,3149,1.14 [1.08-1.21],1.2441630580215353e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26787,475,0.99 [0.87-1.14],0.9242652058748166
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26640,328,0.98 [0.83-1.16],0.8289277724742508
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26911,829,1.23 [1.11-1.37],0.0001002329887235
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27212,75,0.74 [0.55-1.01],0.0572828894052458
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25037,89,1.36 [0.99-1.88],0.0586741216537155
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26360,48,1.26 [0.82-1.96],0.2930271600073013
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,26908,269,1.28 [1.06-1.54],0.0092322188966408
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25368,420,1.12 [0.96-1.30],0.1368595171595599
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,24996,48,0.78 [0.52-1.17],0.231716457586166
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27128,83,0.99 [0.72-1.38],0.974532297370047
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26238,156,1.20 [0.94-1.53],0.1367732308621375
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27005,168,1.25 [0.99-1.58],0.0615660869999804
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,26696,57,1.13 [0.76-1.67],0.5581493809645159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25014,66,0.90 [0.63-1.30],0.5837315532726356
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26544,1596,1.12 [1.04-1.21],0.0028507980170894
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25404,456,1.10 [0.95-1.26],0.2024654678492034
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25000,52,0.83 [0.56-1.24],0.3591230870682008
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27147,310,1.14 [0.96-1.35],0.1492710893164255
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,26722,83,1.45 [1.04-2.02],0.0263434201987368
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27076,239,1.30 [1.07-1.58],0.0095845800914566
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27181,292,1.06 [0.89-1.27],0.4947735068216858
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25110,162,1.08 [0.85-1.37],0.5255098232780251
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25212,264,1.10 [0.91-1.32],0.3300734721162718
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27166,277,1.05 [0.88-1.27],0.5684831310317904
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25146,198,1.42 [1.15-1.74],0.0010202366703396
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27199,154,1.16 [0.91-1.48],0.2236814022139874
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23229,126,0.97 [0.74-1.26],0.8135917500601374
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,24722,6333,1.06 [1.02-1.10],0.0031100828486625
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23341,4952,1.06 [1.02-1.11],0.0061053309833488
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23181,78,0.97 [0.70-1.36],0.8807082985596154
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23353,152,0.96 [0.76-1.22],0.7630459443574656
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23415,214,1.11 [0.91-1.37],0.301677374171431
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,26941,114,0.85 [0.66-1.11],0.2346603902653807
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23320,119,1.53 [1.17-2.01],0.0020853259003658
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19756,1367,1.07 [0.98-1.16],0.1346233882742979
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27082,220,1.05 [0.86-1.29],0.6332107837837462
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23799,598,0.99 [0.87-1.11],0.8157204324833087
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22869,8044,1.05 [1.02-1.09],0.0032750881131906
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24409,141,1.33 [1.03-1.73],0.0289314797566646
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23238,135,1.34 [1.03-1.74],0.0290019420923169
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23791,688,0.94 [0.84-1.05],0.2717853899131542
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26222,3021,1.07 [1.01-1.12],0.0237679471320827
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23280,177,0.99 [0.79-1.23],0.903960876637852
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23490,387,0.97 [0.83-1.12],0.6509906312030067
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23275,172,0.99 [0.79-1.24],0.9087828183940384
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26295,105,1.19 [0.88-1.61],0.2504336165495298
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20260,1871,1.02 [0.95-1.09],0.5757108100765069
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18616,227,1.36 [1.10-1.67],0.003786104407197
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27221,224,1.32 [1.09-1.61],0.0054306079757304
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18487,98,0.69 [0.53-0.90],0.0066166441420224
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18954,565,1.05 [0.92-1.19],0.4791981071651665
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23433,330,0.96 [0.81-1.13],0.6067849874375346
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19019,630,0.96 [0.85-1.08],0.5277816491540961
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23266,65,1.41 [0.97-2.05],0.0722585356546028
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23914,713,1.04 [0.93-1.17],0.4657133517756384
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23532,331,0.96 [0.81-1.13],0.6016613977956546
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18977,588,0.97 [0.86-1.10],0.6096049476812413
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23194,91,1.39 [1.00-1.92],0.0473603875725549
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23171,68,1.15 [0.79-1.66],0.4688921706459653
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24315,47,1.69 [1.11-2.58],0.0143189634053146
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26751,2483,1.13 [1.07-1.20],6.730703374171046e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26054,1786,1.16 [1.08-1.25],4.203537600201547e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27034,599,1.32 [1.16-1.49],1.3208683703381624e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21405,3016,1.11 [1.05-1.17],0.0004025867222408
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18461,72,1.12 [0.78-1.60],0.5366886943447773
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23204,101,1.14 [0.84-1.54],0.4080287253602295
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18431,42,1.28 [0.79-2.08],0.319561695723157
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18588,199,0.97 [0.78-1.20],0.7581061832183158
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24561,293,0.91 [0.77-1.08],0.2873439598792381
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,24845,577,1.17 [1.03-1.33],0.0179117445783545
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27203,109,1.17 [0.88-1.57],0.2816064489248028
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25239,2038,1.05 [0.98-1.12],0.1333808532333068
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23234,131,1.10 [0.85-1.44],0.4704930428840908
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18620,231,1.20 [0.98-1.47],0.0769410455274505
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24005,804,0.98 [0.88-1.09],0.6927828761751308
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20918,2529,1.06 [0.99-1.12],0.0743851014586444
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26319,129,1.32 [1.01-1.73],0.0437143008293514
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27213,75,1.53 [1.08-2.16],0.0154774455639955
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23186,83,0.97 [0.70-1.35],0.8759415888599575
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24571,1468,1.15 [1.07-1.25],0.0003808353718919
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23186,83,1.37 [0.98-1.91],0.069784988988869
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20362,1973,1.07 [1.00-1.15],0.0477172414009131
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24404,136,0.76 [0.60-0.97],0.0265075945349159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23164,61,1.29 [0.87-1.92],0.2022578394833916
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23401,200,1.01 [0.82-1.25],0.9084868266144012
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23686,583,1.23 [1.09-1.40],0.0010384641813203
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26690,500,1.26 [1.10-1.45],0.0007956960324631
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23852,651,1.12 [0.99-1.26],0.0616297285782558
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27049,580,1.34 [1.18-1.52],5.164354419421937e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27205,67,1.66 [1.16-2.38],0.0054455045877275
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23327,224,0.88 [0.73-1.07],0.1965910042121026
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20885,913,1.11 [1.01-1.23],0.0380086950363474
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23767,664,1.13 [1.01-1.27],0.0408661081084512
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23226,123,1.08 [0.82-1.42],0.5842481708416343
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18466,77,1.33 [0.93-1.90],0.1135426609847186
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21016,2627,1.12 [1.06-1.19],0.000181432208716
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19227,838,1.10 [0.99-1.22],0.0840733371376371
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,26488,298,1.14 [0.95-1.36],0.1542844709376862
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27175,81,1.11 [0.79-1.56],0.5382758219486894
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",24935,52,0.87 [0.62-1.23],0.4377900598420443
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18465,76,1.59 [1.12-2.26],0.0090303092551
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23311,110,1.39 [1.04-1.85],0.0248892522883575
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18991,602,1.34 [1.18-1.52],6.368563203117709e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23431,328,1.03 [0.88-1.22],0.7012775427126372
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23485,284,1.07 [0.89-1.28],0.468256435848236
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23478,277,1.01 [0.84-1.21],0.909657462062164
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21032,84,0.98 [0.70-1.35],0.8803686329386511
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27212,74,1.63 [1.16-2.30],0.0049557678908577
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23742,639,1.00 [0.89-1.12],0.9549675513731972
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],26346,156,1.63 [1.29-2.06],5.289354442113001e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25909,2806,1.07 [1.01-1.13],0.0161262181120479
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23259,156,1.12 [0.88-1.43],0.3651028481346422
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23768,567,1.15 [1.01-1.30],0.0333763625564014
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,25518,264,1.12 [0.93-1.34],0.2500870942348474
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23474,273,0.85 [0.72-1.01],0.0644697504460655
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24956,1755,1.09 [1.01-1.17],0.0253669918058379
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24398,1197,1.07 [0.98-1.17],0.105633745379065
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23167,64,0.92 [0.64-1.31],0.6337610815704254
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26408,218,1.67 [1.37-2.03],4.595782410424239e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23307,204,0.89 [0.73-1.10],0.2885228687308745
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23230,127,1.23 [0.93-1.61],0.1423680838222975
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18443,54,1.05 [0.69-1.59],0.8337659443659279
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26163,1254,1.56 [1.43-1.69],5.412644942212374e-25
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20386,101,1.12 [0.83-1.51],0.4599298284379751
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26533,111,0.95 [0.72-1.26],0.7272942840971843
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27073,230,1.10 [0.90-1.34],0.355449227853069
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,26871,28,0.88 [0.50-1.53],0.6474924753078721
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26398,1489,1.52 [1.41-1.64],1.1955455594938123e-26
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27056,76,1.30 [0.93-1.83],0.1242211429419515
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27025,243,1.18 [0.97-1.43],0.0999151032195198
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cystitis,24015,245,1.08 [0.89-1.31],0.4346442844752536
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Dialysis,24964,55,2.36 [1.67-3.35],1.2061616981157324e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26762,340,1.05 [0.89-1.23],0.5775397034105616
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Endometriosis,20462,177,0.99 [0.79-1.23],0.8967210234124524
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20682,397,0.90 [0.78-1.05],0.1888303650637198
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21287,1002,1.05 [0.95-1.15],0.3298481126028395
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21195,5026,1.14 [1.09-1.19],4.382574659857175e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27044,64,1.78 [1.25-2.52],0.0012160944077676
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,24787,212,0.98 [0.80-1.21],0.8840998107976411
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26693,393,1.00 [0.86-1.16],0.9616103055797558
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Irregular menses,26772,130,0.98 [0.75-1.28],0.8891944224406605
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20590,305,0.91 [0.77-1.08],0.2648672963019997
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23849,79,1.20 [0.85-1.68],0.3051553907792074
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22718,2433,1.02 [0.96-1.09],0.4658595694301762
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20426,141,1.09 [0.85-1.41],0.489873732534369
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27219,62,0.91 [0.63-1.32],0.617034501269057
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27223,72,1.28 [0.90-1.82],0.1681485572794077
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25988,2218,1.16 [1.09-1.24],4.044310159715989e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24238,468,1.08 [0.94-1.24],0.2739158862976382
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26542,120,1.06 [0.80-1.39],0.6951259053911922
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27172,390,1.32 [1.13-1.53],0.0004342565074166
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27172,91,0.99 [0.72-1.35],0.9366555853644812
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25682,1912,1.20 [1.12-1.28],3.697927926453781e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26501,201,0.95 [0.77-1.17],0.6224673972346992
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20436,151,0.99 [0.78-1.26],0.9302637737281868
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20652,367,1.00 [0.85-1.16],0.9523288152581816
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20394,109,1.21 [0.90-1.62],0.2010545281152077
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20489,204,0.92 [0.75-1.13],0.4471652462480272
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24840,265,1.03 [0.85-1.24],0.7917675474852344
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,26910,128,1.44 [1.11-1.86],0.0066231025199028
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20590,305,1.00 [0.84-1.18],0.969420130931448
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20392,107,0.75 [0.58-0.98],0.0364129962478034
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20922,637,0.97 [0.86-1.09],0.6192824800294958
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20443,158,1.08 [0.85-1.38],0.5150794360813635
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20867,582,1.06 [0.94-1.21],0.3248970898693546
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27018,38,1.60 [0.99-2.60],0.0572779777207021
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27035,2460,1.38 [1.29-1.46],8.729447226099682e-25
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",24740,165,1.35 [1.06-1.73],0.0142254925655921
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25012,103,1.84 [1.39-2.44],2.191082206692076e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26878,35,1.06 [0.64-1.76],0.8311311943209043
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23909,139,1.19 [0.92-1.55],0.1847273611970131
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27108,265,1.09 [0.91-1.31],0.3529992338833786
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20427,142,0.92 [0.72-1.18],0.520021233270495
